
After a median follow-up of 10 months, the overall response rate in patients with PD-L1-expressing metastatic breast cancer was 33.3 percent.

After a median follow-up of 10 months, the overall response rate in patients with PD-L1-expressing metastatic breast cancer was 33.3 percent.

It's amazing how we feel the need to apologize. We want to make others comfortable. Sometimes it just doesn't work.

Sadly, we cancer survivors are often measured by what we’ve lost to cancer. I would like to put something back in the space left by all the things taken away.

The DigniCap Cooling System reduces the severity and frequency of hair loss in patients receiving chemotherapy for breast cancer.

The addition of the PD-1 inhibitor Keytruda (pembrolizumab) to an established multiple myeloma regimen elicited responses in 76 percent of 17 patients with relapsed/refractory disease.

Millions of people worldwide hear these words every year.

Exactly one month after an oncologist told her that there was an 80 percent chance she was free of colon cancer, Taylor Arnold sat in front of a panel of patients, survivors and doctors, wondering why she was there.

In updated data from a phase 3 study, the addition of Empliciti reduced the risk of progression or death by 27 percent.

The results showed a two-year overall survival rate of 98 percent with Imbruvica.

Over five years out from breast cancer and over a year from melanoma, I still stress out about scans, tests and mammograms.

Genetically engineered T cells eradicated multiple myeloma cells in a single patient with advanced disease.

We often have to face things in illnesses that feel bigger than we think we can manage, yet somehow we balance the fear with the hope and find humanity in the process.

If you have a family member who is sick or terminally ill, my advice to approach a holiday is to remain festive, even if the person you want to celebrate does not appear inclined to join in too many festivities. The holiday may become one you will never forget.

Former U.S. president Jimmy Carter once again provided an update on his health today.

At CURE's Third Annual MPN Heroes celebration, "grace" was the word of the night.

The responsibility of caregiving is increasingly being placed on family members.

I feel terror and beauty all around me, but it's OK to feel them both — they've gotten me this far.

Breast cancer and melanoma survivor reflects on coping with cancer's challenges during the holidays.

Cancer hit me with guilt the moment it came into my life. Even now, six years later, it's still part of my cancer experience.

Many patients who have had melanoma do not conduct regular skin self-examinations, and those who do check themselves do not use sufficient tools or techniques.

Those who had taken birth control pills prior to their cancer diagnosis had improved progression-free survival compared with those who had not taken contraceptives.

While recent advances in breast cancer therapy have resulted in survival gains, many patients and survivors have an increased risk of cardiovascular adverse events following treatment.

As an animal lover and psychotherapist, I've seen the healing power of pet therapy firsthand. From horses to dogs, cats and rabbits, the impact that animals have on recovery is nothing short of miraculous.

Most cancer survivors are familiar with Psalm 23 and the feeling of walking through the valley of the shadow. We also need to remember that there's another side to the valley, where the light shines brightly.

Immunotherapies continue to be studied and approved across multiple tumor types, among them, malignancies of the central nervous system.

The approval was based on data from the phase 3 ELOQUENT-2 trial, in which adding Empliciti to standard Revlimid (lenalidomide)/dexamethasone reduced the risk of disease progression by 30 percent.

The treatment paradigm for patients with triple-negative breast cancer is set to undergo a dramatic transformation, as standard chemotherapeutic approaches are perfected and novel antibody-drug conjugates are developed.

Every cancer conference is a chance for me to learn.

My mother chose to live by asking for help, and so can I.